🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Polyneuropathy

Longitudinal Quantitative Neuromuscular MRI in Neuropathic Patients NCT06845644NA1 site📍 Marseille Assistance Publique Hopitaux De Marseille · Tests: Quantitative neuromuscular MRI, Neuromuscular ultrasound A Study of HyQvia in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) in Routine Clinical Care NCT06538064n/a15 sites📍 Rancho Mirage📍 San Francisco📍 New Haven Takeda · Tests: No Intervention Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health Clinical Trial With Aconite Pain Oil in Oncology Patients Under Chemotherapy to Prevent CIPN, to Reduce Symptoms and to Improve the Quality of Life of Patients With CIPN NCT06186479Phase 31 site📍 Mannheim WALA Heilmittel GmbH · Tests: Aconite pain oil, Placebo Our Study Aims to Determine if Nerve Alterations in Acute GBS and CIDP Detectable by Ultrasound Match Electrodiagnostic Findings and if This Method Aids Early Diagnosis, Predict Their Outcomes and Differentiate Between Axonal and Demyelinating Subtypes. NCT06615622n/a1 site📍 Asyut Assiut University · Tests: Placebo A Study of AZD2962, an IRAK4 Inhibitor (IRAK4 [a Body Protein] Blocker), in Participants With Haematologic Neoplasms (Blood Cancers) NCT07064122Phase 121 sites📍 Miami📍 Tampa📍 Houston AstraZeneca · Tests: AZD2962 Carboplatin or Olaparib for BRcA Deficient Prostate Cancer NCT04038502Phase 218 sites📍 West Los Angeles📍 Aurora📍 Washington D.C. VA Office of Research and Development · Tests: Carboplatin, Olaparib Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity NCT07674290Phase 41 site📍 Essen Tom Hühne · Tests: Setmelanotide AUTONOMOUS DISORDERS IN CMT NCT07570446n/a1 site📍 Göttingen University Medical Center Goettingen Study of ACR-2316 in Specific Advanced Solid Tumors NCT06667141Phase 1, Phase 215 sites📍 Phoenix📍 Beverly Hills📍 Newport Beach Acrivon Therapeutics · Tests: ACR-2316 A Prospective Cohort Study of Surgical Treatment for Foot Deformities in HSP NCT06936163n/a1 site📍 Shanghai Shanghai 6th People's Hospital Comparative Study of Combination Treatment of Bionerv E+ Versus Vitamin B Complex in Treatment of Diabetic Polyneuropathy in Type 2 Diabetic Patients and Its Effect on Wound Healing NCT07877948NA1 site📍 Cheras BREGO Life Sciences · Tests: Alpha-Lipoic Acid, Vitamin B1, Vitamin B6, Vitamin B12, Vitamin E, Vitamin B1, Vitamin B6, Vitamin B12 Registry for Adults With Plasma Cell Disorders (PCD's) NCT03717844n/a1 site📍 Chapel Hill UNC Lineberger Comprehensive Cancer Center Normast3 for Adults With Diabetic Polyneuropathy NCT07689214NA1 site📍 Rome University of Roma La Sapienza · Tests: Normast® 3 - a food for special medical purposes (FSMP) containing co-micronized palmitoylethanolamide (PEA) with rutin… Sapanisertib and Serabelisib (PIKTOR) in Various Combinations in Patients With HR+/HER2- Advanced/Metastatic Breast Cancer NCT07558733Phase 1, Phase 27 sites📍 Los Angeles📍 Lone Tree📍 Springfield Faeth Therapeutics · Tests: Serabelisib, Sapanisertib, Fulvestrant Subcutaneous Immunoglobulin Therapy Effectiveness Monitoring in CIDP Patients Using Smart Devices NCT07273903n/a2 sites📍 Düsseldorf📍 Münster Heinrich-Heine University, Duesseldorf Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer NCT06463028Phase 218 sites📍 La Jolla📍 San Francisco📍 Miami Beach Faeth Therapeutics · Tests: Sapanisertib, Serabelisib, Paclitaxel A Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy NCT07540221Phase 315 sites📍 Rancho Mirage📍 Coral Springs📍 Miami Grifols Therapeutics LLC · Tests: Gamunex-C, Xembify Spastic Paraplegia - Centers of Excellence Research Network NCT06553976n/a11 sites📍 Miami📍 Iowa City📍 Boston Boston Children's Hospital Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis NCT06465810n/a89 sites📍 La Jolla📍 Los Angeles📍 San Francisco AstraZeneca · Tests: Treatment of transthyretin (ATTR) amyloidosis in observational study setting Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP) NCT06968975n/a1 site📍 Swiftwater Sanofi Rare Disease Registry Database for Movement Disorders in Southern Anhui Province NCT07838883n/a1 site📍 Wuhu First Affiliated Hospital of Wannan Medical College Studying Nerve Function and Structure in Charcot-Marie-Tooth Disease, Anti-MAG Neuropathy and CIDP NCT07461896n/a1 site📍 Milan Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Online Study of People Who Have Genetic Changes and Features of Autism: Simons Searchlight NCT01238250n/a2 sites📍 Boston📍 Lewisburg Simons Searchlight Natural History of Sphingosine Phosphate Lyase Insufficiency Syndrome (SPLIS) NCT06669949n/a1 site📍 San Francisco University of California, San Francisco · Tests: no intervention Assessment of the Efficacy and Safety of Alpelisib (BYL719) in Pediatric and Adult Patients With Megalencephaly-CApillary Malformation Polymicrogyria Syndrome (MCAP) NCT05577754Phase 213 sites📍 Amiens📍 Angers📍 Brest Centre Hospitalier Universitaire Dijon · Tests: Alpelisib (BYL719), Matching placebo, Optional lumbar puncture + blood sample Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment NCT07304154Phase 110 sites📍 Newport Beach📍 Palo Alto📍 New York Kite, A Gilead Company · Tests: KITE-363, Fludarabine, Cyclophosphamide First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors NCT05768139Phase 1, Phase 265 sites📍 Los Angeles📍 San Francisco📍 Aurora Eli Lilly and Company · Tests: STX-478, Fulvestrant, Ribociclib, Palbociclib, Letrozole Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi NCT06599619n/a1 site📍 Pittsburgh John Kirkwood · Tests: Single agent, adjuvant anti-PD1 therapy Improved Recovery of Walking in Acquired Muscle Weakness NCT06786390NA1 site📍 Milan Fondazione Don Carlo Gnocchi ETS · Tests: Rehabilitation protocol: FES, Rehabilitation protocol without FES, Rehabilitation protocol: FES
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy